Cite
Inhibition of Epidermal Growth Factor Receptor Activation Is Associated With Improved Diabetic Nephropathy and Insulin Resistance in Type 2 Diabetes.
MLA
Zhilian Li, et al. “Inhibition of Epidermal Growth Factor Receptor Activation Is Associated With Improved Diabetic Nephropathy and Insulin Resistance in Type 2 Diabetes.” Diabetes, vol. 67, no. 9, Sept. 2018, pp. 1847–57. EBSCOhost, https://doi.org/10.2337/db17-1513.
APA
Zhilian Li, Yan Li, Overstreet, J. M., Sungjin Chung, Aolei Niu, Xiaofeng Fan, Suwan Wang, Yinqiu Wang, Ming-Zhi Zhang, Harris, R. C., Li, Z., Li, Y., Chung, S., Niu, A., Fan, X., Wang, S., Wang, Y., & Zhang, M.-Z. (2018). Inhibition of Epidermal Growth Factor Receptor Activation Is Associated With Improved Diabetic Nephropathy and Insulin Resistance in Type 2 Diabetes. Diabetes, 67(9), 1847–1857. https://doi.org/10.2337/db17-1513
Chicago
Zhilian Li, Yan Li, Jessica M. Overstreet, Sungjin Chung, Aolei Niu, Xiaofeng Fan, Suwan Wang, et al. 2018. “Inhibition of Epidermal Growth Factor Receptor Activation Is Associated With Improved Diabetic Nephropathy and Insulin Resistance in Type 2 Diabetes.” Diabetes 67 (9): 1847–57. doi:10.2337/db17-1513.